GENZYME CORPORATION GENZ (NASDAQ)

$ 75.92
19:10
Change: unch (unch%)
Volume: 6,600,433

Avg. Volume: 3986677
P/E Ratio: 25
EPS (Annual): 1.89
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 267,630
Institutional Shareholders: 86.92%
Last: 75.92
Change: unch (unch%)
Prev. Close: 75.92
Open: 77.18
Day's Range: 75.56 - 77.97
52wk Range: 58.71 - 82.08
Market Value: 20,911,900
Beta: .4
12-month EPS Change: 752.94%
Total Return Last 12 Months: +31.10%
Total Return Last 3 Years: +18.99%
Total Return Last 5 Years: +57.19%
5-Year Revenue Growth Rate: 253.04%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 119.28%


Headlines on GENZ

Genzyme shares fall on more Myozyme delays

(NEW YORK)Shares of Genzyme Corp. fell Wednesday after the company reported positive second-quarter financial results but said plans to increase production of its genetic disorder drug Myozy...READ MORE
Jul 23, 2008 8:40PM
Keywords: GENZ

Earnings roundup: ConocoPhillips, Philip Morris

Among the earnings stories for Wednesday, July 23, from AP Financial News: Top stories:READ MORE
Jul 23, 2008 10:28AM
Keywords: ATI, GENZ, AMG

Genzyme 2Q profit falls on drug licensing charge

(CAMBRIDGE, Mass.)Biotechnology company Genzyme Corp. said Wednesday its second-quarter profit fell on a series of charges, though adjusted profit and revenue topped Wall Street forecasts.READ MORE
Jul 23, 2008 9:23AM
Keywords: GENZ

Sector Snap: Biotech stocks rise on buyout offer

(NEW YORK)Shares throughout the biotechnology sector advanced Monday as Swiss pharmaceutical giant Roche offered to buy Genentech Inc. in potentially the biggest pharma-biotech deal of the y...READ MORE
Jul 21, 2008 11:42AM
Keywords: DNA, BIIB, IMCL, AMLN, AMGN, CELG, GENZ

Family sues co. for muscular dystrophy drug

(WASHINGTON)A Minnesota family is trying to force a New Jersey drug company to give their son an experimental drug for a fatal form of muscular dystrophy, saying he'll die without it.READ MORE
Jul 17, 2008 9:13PM
Keywords: GENZ

Genzyme licenses rights to genetic disorder drug

(CAMBRIDGE, Mass.)Biotechnology company Genzyme Corp. said Thursday it will pay PTC Therapeutics Inc. $100 million upfront to license rights to a developing treatment for genetic disorders.READ MORE
Jul 17, 2008 10:17AM
Keywords: GENZ

New pharma ethics rules eliminate gifts and meals

(NEW YORK)Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occa...READ MORE
Jul 11, 2008 5:28AM
Keywords: JNJ, MRK, AMGN, AZN, BMY, PFE, GSK, NVS, LLY, SGP, ABT, TEVA, BIIB, DNA, GENZ, GIL, D, CELG, NVO, SNY, WYE
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +6.50 53.92
GILEAD SCIENCES +37.60 52.70
GENENTECH INC +36.30 93.73
CELGENE CP +22.00 70.45
BIOGEN IDEC INC +29.90 71.38